Systematic review / meta-analysis / 2019
Collagen supplementation significantly reduced total WOMAC index, stiffness subscore, and VAS score in osteoarthritis patients.
A meta-analysis of randomized placebo-controlled trials was conducted to evaluate oral collagen supplementation on osteoarthritis symptoms using a random-effects model. Collagen treatment significantly reduced the total WOMAC index (WMD -8.00; 95% CI -13.04, -2.95; p = 0.002) and VAS score (WMD -16.57; 95% CI -26.24, -6.89; p < 0.001). Subgroup analysis of WOMAC subscores showed a significant decrease in stiffness (WMD -0.41; 95% CI -0.74, -0.08; p = 0.01), but no significant differences were observed for pain (WMD -0.22; 95% CI -1.58, 1.13; p = 0.75) or functional limitation (WMD -0.62; 95% CI -5.77, 4.52; p = 0.81).
- Study type
- Meta-analysis of randomized placebo-controlled trials
- Who was studied
- Patients with osteoarthritis evaluated across randomized placebo-controlled trials
- What was measured
- Total WOMAC index, WOMAC subscores (stiffness, pain, functional limitation), and VAS score
THE PAPER
Effect of collagen supplementation on osteoarthritis symptoms: a meta-analysis of randomized placebo-controlled trials.
García-Coronado JM, Martínez-Olvera L, Elizondo-Omaña RE, Acosta-Olivo CA, Vilchez-Cavazos F, Simental-Mendía LE, Simental-Mendía M. Int Orthop, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.